Understanding early autism evaluations and why it matters whether a developmental pediatrician or a clinical psychologist ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Despite the risk of subsequent fractures in patients with osteoporosis, only approximately 20% of patients nationally receive ...

A local regulatory body aimed at approving medications independently is slated to begin operations by the end of next year, ...

Duke University School of Medicine researchers have developed two pioneering frameworks designed to evaluate the performance, ...

SAN DIEGO--(BUSINESS WIRE)--Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell ...

Panelists discuss how incorporating subcutaneous (SubQ) formulations into clinical formularies requires careful evaluation of clinical equivalence, workflow fit, and reimbursement logistics, with ...

An expert emphasizes that treatment decisions for metastatic castration-resistant prostate cancer (mCRPC) are highly ...

China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Two newly developed PET imaging agents have been proven effective in identifying the histamine H3 receptor (H3R) that is highly expressed in neurological and psychiatric conditions. The novel agents ...